Profile of conbercept in the treatment of neovascular age-related macular degeneration
Xinmin Lu,1 Xiaodong Sun1–31Department of Ophthalmology, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Eye Research Institute of Shanghai Jiao Tong University, Shanghai, People’s Rep...
Main Authors: | Lu XM, Sun XD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/profile-of-conbercept-in-the-treatment-ofnbspneovascular-age-related-m-peer-reviewed-article-DDDT |
Similar Items
-
Intravitreal conbercept injection for neovascular age-related macular degeneration
by: Bing-Hui Wu, et al.
Published: (2019-02-01) -
Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
by: Dan Călugăru, et al.
Published: (2020-02-01) -
Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01) -
Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
by: Wang LP, et al.
Published: (2018-10-01) -
Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration
by: Keane PA, et al.
Published: (2015-02-01)